A drug with the SMILES CCN1CCN(CCNC(=O)c2ccc3c(c2)N(Cc2cccc(Cl)c2)C(=O)c2ccccc2S3=O)CC1 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 12.892\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CCN1CCN(CCNC(=O)c2ccc3c(c2)N(Cc2cccc(Cl)c2)C(=O)c2ccccc2S3=O)CC1
CCN1CCN(CCNC(=O)c2ccc3c(c2)N(Cc2cccc(Cl)c2)C(=O)c2ccccc2S3=O)CC1
5-[(3-chlorophenyl)methyl]-N-[2-(4-ethylpiperazin-1-yl)ethyl]-6,11-dioxobenzo[b][1,4]benzothiazepine-3-carboxamide